Biomarkers: Detecting Alzheimer's Early Enoug...

How imaging is used in translational neuroscience. 

Movement and exercise and it's relation to thinking and cognition. 

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ...  Show more

<pre class="syntaxhighlighter-pre" data-syntaxhighlighter-params= "brush: xml; gutter: false; theme: Midnight" data-theme= "Midnight">Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit ...  Show more

The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This pod ...

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology. Read the full article: Comparison of amyloid burden ...  Show more